Drug intelligence / Profile preview

fufang yuxingcao oral solution

Development stage
Unknown
Lead developer
Conba Pharmaceutical
Administration
Oral
01

Overview

Fufang Yuxingcao oral solution is a Traditional Chinese Medicine (TCM) compound preparation developed and manufactured by Zhejiang Conba Pharmaceutical. It is formulated based on the "wind-heat" pattern theory of TCM and is primarily indicated for the treatment of acute pharyngitis, tonsillitis, and other upper respiratory tract infections. The solution typically contains extracts from five key medicinal herbs: *Houttuynia cordata* (Yuxingcao), *Scutellaria baicalensis* (Huangqin), *Forsythia suspensa* (Lianqiao), *Lonicera japonica* (Jinyinhua), and *Isatis tinctoria* (Banlangen). These components provide a combination of anti-inflammatory, antibacterial, and antiviral effects. The drug is currently undergoing Phase II clinical trials (e.g., CTR20244962) to evaluate the efficacy and safety of high-dose regimens in pediatric patients aged 3 to 12 years with acute pharyngitis.

Brand names
Conba
Other names
Compound Houttuynia Oral SolutionFufang Yuxingcao Koufuye

Beyond the preview

Go deeper on fufang yuxingcao oral solution.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fufang yuxingcao oral solution.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call